✦ LIBER ✦

Ganglioside analysis of metastatic malignant melanoma with unknown primary lesion

✍ Scribed by Nakano, Junji; Imamura, Takashi; Hamanaka, Sumiko; Ota, Takahisa; Asagami, Chidori

Book ID: 123341550
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 157 KB
Volume: 1
Category: Article
ISSN: 0923-1811
DOI: 10.1016/0923-1811(90)90244-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignant melanoma of the chest wall wit

Malignant melanoma of the chest wall with an unknown primary lesion

✍ Goichi Yotsumoto; Shinji Shimokawa; Akihiro Yamaoka; Shun-ichi Watanabe; Yoshifu 📂 Article 📅 1998 🏛 Springer Japan 🌐 Japanese ⚖ 651 KB

Malignant melanoma of the stomach presen

Malignant melanoma of the stomach presenting with an unknown primary lesion

✍ T. G. Iconomou; D. Tsoutsos; K. Frangia; H. Gogas; S. Papadopoulos; V. Georgount 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 106 KB

Dermatomyositis and metastatic malignant

Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesion

✍ G. Sais; I. Marcoval; A. Jucgla; N. Curgo; O. Servitje 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Chronic inflammatory demyelinating polyn

Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin

✍ José-Alberto Palma; Salvador Martín-Algarra 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 108 KB

Renal Metastasis of Malignant Melanoma w

Renal Metastasis of Malignant Melanoma with Unknown Primary

✍ Mark S. Shimko; Stephen C. Jacobs; Michael W. Phelan 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 578 KB

Metastatic malignant melanoma of unknown

Metastatic malignant melanoma of unknown primary origin: A study of 30 cases

✍ Emmanuel Panagopoulos; Douglas Murray 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

Thirty patients with metastatic malignant melanoma of unknown primary origin treated at Emory University Clinic between 1940 and 1975 are presented. This group represents the 4.4% of all melanomas treated during the same period of time at Emory. Nineteen (63.3%) patients had nodal metastases only, a